Pancrelipase Side Effects|
|
Did You Have a Pancrelipase Side Effect? How Effective is Pancrelipase for You? |
Pancrelipase Forum |
Pancrelipase Adverse Effect Reports (FDA)
Hyperglycaemia, White Blood Cell Count Decreased, Decreased Appetite, Platelet Count Decreased, Vomiting, Insomnia, Anaemia, Rash, Oesophageal Varices Haemorrhage (8428939-0)
on Jun 04, 2012 Male patient from JAPAN , weighting 125.7 lb, was treated with Pancrelipase(View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia, white blood cell count decreased, decreased appetite, platelet count decreased, vomiting, insomnia, anaemia, rash (rash Questions), oesophageal varices haemorrhage. Pancrelipase dosage: 450 Mg, Uid/qd.
Patient was taking other medications:
Secondary Adrenocortical Insufficiency, Syncope, Upper Respiratory Tract Infection, Infective Pulmonary Exacerbation Of Cystic Fibrosis (8310419-4)
Patient was taking Pancrelipase (View Usage). Patient had the following side effects: secondary adrenocortical insufficiency, syncope, upper respiratory tract infection, infective pulmonary exacerbation of cystic fibrosis on Apr 18, 2012 from UNITED STATES Additional patient health information: Female patient , weighting 99.43 lb, . Pancrelipase dosage: N/A.
Patient was taking other medications:
Carcinoid Tumour (8216416-1)
Adverse event was reported on Mar 12, 2012 by a Male patient taking Pancrelipase (View Usage) (Dosage: N/A) . Location: UNITED STATES , weighting 212.0 lb, After Pancrelipase was administered, patient had the following side effects: carcinoid tumour.
Patient was taking other medications:
Abdominal Distension, Abdominal Discomfort, Diarrhoea, Nausea (8013261-7)
on Dec 29, 2011 Male patient from UNITED STATES , weighting 150.0 lb, was diagnosed with
Abdominal Distension, Decreased Appetite, Nausea (7955033-5)
on Nov 25, 2011 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with
Patient was taking other medications: Patient was hospitalized.
Dehydration, Vomiting, Diarrhoea (7948865-0)
Patient was taking Pancrelipase Mt 10 (View Usage). After Pancrelipase was administered, patient had the following side effects: dehydration, vomiting, diarrhoea on Nov 21, 2011 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 220.5 lb, . Pancrelipase Mt 10 dosage: 30,000-10,000-30,000.
Patient was taking other medications:
Eye Disorder (7897970-6)
Adverse event was reported on Oct 27, 2011 by a Male patient taking Pancrelipase (View Usage) (Dosage: Unk) was diagnosed with
Patient was taking other medications:
Eye Disorder (7833242-3)
on Oct 19, 2011 Male patient from UNITED STATES , weighting 136.7 lb, was diagnosed with
Patient was taking other medications:
Gastroenteritis, Frequent Bowel Movements (7767629-4)
on Sep 07, 2011 Female patient from UNITED STATES , weighting 13.45 lb, was diagnosed with
Patient was taking other medications:
Headache, Dizziness, Dry Mouth, Abnormal Faeces (7647985-8)
Patient was taking Pancrelipase (View Usage). Patient experienced the following unwanted or unexpected effects: headache (headache Questions), dizziness (dizziness Questions), dry mouth, abnormal faeces on Jun 21, 2011 from UNITED STATES Additional patient health information: Male patient , weighting 150.3 lb, was diagnosed with
Patient was taking other medications:
Scar, Skin Induration, Fibrosis, Dizziness, Nephrogenic Systemic Fibrosis, Mobility Decreased, Arthralgia, Bone Pain, Injury (7599492-9)
Adverse event was reported on Aug 29, 2008 by a Female patient taking Pancrelipase (View Usage) (Dosage: N/A) . Location: UNITED STATES , 43 years of age, weighting 156.0 lb, Patient had the following side effects: scar (scar Questions), skin induration, fibrosis, dizziness (dizziness Questions), nephrogenic systemic fibrosis, mobility decreased, arthralgia, bone pain, injury.
Patient was taking other medications:
Abdominal Distension, Dyspnoea Exertional, Hypoalbuminaemia, Metastatic Pain, Fatigue, Nausea, Decreased Appetite, Anaemia, Biliary Cancer Metastatic (7548565-5)
on May 31, 2011 Female patient from UNITED STATES , 60 years of age, weighting 121.5 lb, was treated with Pancrelipase (View Usage). After Pancrelipase was administered, patient had the following side effects: abdominal distension, dyspnoea exertional, hypoalbuminaemia, metastatic pain, fatigue, nausea (nausea Questions), decreased appetite, anaemia, biliary cancer metastatic. Pancrelipase dosage: N/A.
Patient was taking other medications:
Hypoglycaemia, Gait Disturbance, Fracture, Arthralgia, Blood Pressure Increased (7424643-6)
on Apr 18, 2011 Female patient from UNITED STATES , weighting 178.0 lb, was diagnosed with
Patient was taking other medications:
Anaemia, Pancreatitis Acute, Pancreatitis Chronic (6058247-7)
Patient was taking Pancrelipase Delayed Release Capsules (View Usage). Patient had the following side effects: anaemia, pancreatitis acute, pancreatitis chronic on Jan 22, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 223.5 lb, was diagnosed with
Pancreatitis Acute (5947850-8)
Adverse event was reported on Oct 28, 2008 by a Female patient taking Pancrelipase Delayed Release Capsules (View Usage) (Dosage: Daily Dose: 4 Capsules (one Capsule Per Meal/snack)) was diagnosed with
Patient was taking other medications:
Abdominal Pain, Dehydration, Diarrhoea, Dizziness, Frequent Bowel Movements, Malaise, Nausea, Stomach Discomfort (4806777-5)
on Oct 19, 2005 Male patient from UNITED STATES , 52 years of age, weighting 243.0 lb, was diagnosed with
on Jun 04, 2012 Male patient from JAPAN , weighting 125.7 lb, was treated with Pancrelipase(View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia, white blood cell count decreased, decreased appetite, platelet count decreased, vomiting, insomnia, anaemia, rash (rash Questions), oesophageal varices haemorrhage. Pancrelipase dosage: 450 Mg, Uid/qd.
Patient was taking other medications:
- MAGMITT (View Magmitt Review and Magmitt Label )
- FENTANYL CITRATE (2 Mg, Uid/qd) (View Fentanyl Citrate Review and Fentanyl Citrate Label )
- SANDOSTATIN (200 Ug, Uid/qd) (View Sandostatin Review and Sandostatin Label )
- RABEPRAZOLE SODIUM (10 Mg, Uid/qd) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label )
- LYRICA (150 Mg, Uid/qd) (View Lyrica Review and Lyrica Label )
- GEMCITABINE HYDROCHLORIDE (1000 Mg/m2, Uid/qd) (View Gemcitabine Hydrochloride Review and Gemcitabine Hydrochloride Label )
- OXYCONTIN (40 Mg, Uid/qd) (View Oxycontin Review and Oxycontin Label )
- SENNA MINT WAF (24 Mg, Uid/qd) (View Senna-mint Waf Review and Senna-mint Waf Label )
Secondary Adrenocortical Insufficiency, Syncope, Upper Respiratory Tract Infection, Infective Pulmonary Exacerbation Of Cystic Fibrosis (8310419-4)
Patient was taking Pancrelipase (View Usage). Patient had the following side effects: secondary adrenocortical insufficiency, syncope, upper respiratory tract infection, infective pulmonary exacerbation of cystic fibrosis on Apr 18, 2012 from UNITED STATES Additional patient health information: Female patient , weighting 99.43 lb, . Pancrelipase dosage: N/A.
Patient was taking other medications:
- IVACAFTOR (View Ivacaftor Review and Ivacaftor Label )
- LEVALBUTEROL HCL (View Levalbuterol Hcl Review and Levalbuterol Hcl Label )
- PREDNISONE (View Prednisone Review and Prednisone Label )
- ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label )
- PULMOZYME (View Pulmozyme Review and Pulmozyme Label )
- ADEKS (View Adeks Review and Adeks Label )
- AZTREONAM (View Aztreonam Review and Aztreonam Label )
- IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label )
Carcinoid Tumour (8216416-1)
Adverse event was reported on Mar 12, 2012 by a Male patient taking Pancrelipase (View Usage) (Dosage: N/A) . Location: UNITED STATES , weighting 212.0 lb, After Pancrelipase was administered, patient had the following side effects: carcinoid tumour.
Patient was taking other medications:
- TEKTURNA (View Tekturna Review and Tekturna Label )
- ATIVAN (View Ativan Review and Ativan Label )
- CLONIDINE (View Clonidine Review and Clonidine Label )
- SEROQUEL (View Seroquel Review and Seroquel Label )
- NORCO (View Norco Review and Norco Label )
- TOBI (300 Mg, Bid, 14 Days On And 14 Days Off) (View Tobi Review and Tobi Label )
- CARDIZEM (View Cardizem Review and Cardizem Label )
- COREG (View Coreg Review and Coreg Label )
Abdominal Distension, Abdominal Discomfort, Diarrhoea, Nausea (8013261-7)
on Dec 29, 2011 Male patient from UNITED STATES , weighting 150.0 lb, was diagnosed with
- pancreatitis chronic
Abdominal Distension, Decreased Appetite, Nausea (7955033-5)
on Nov 25, 2011 Female patient from JAPAN , weighting 94.80 lb, was diagnosed with
- pancreatic enzymes abnormal
Patient was taking other medications: Patient was hospitalized.
Dehydration, Vomiting, Diarrhoea (7948865-0)
Patient was taking Pancrelipase Mt 10 (View Usage). After Pancrelipase was administered, patient had the following side effects: dehydration, vomiting, diarrhoea on Nov 21, 2011 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 220.5 lb, . Pancrelipase Mt 10 dosage: 30,000-10,000-30,000.
Patient was taking other medications:
- AXITINIB (View Axitinib Review and Axitinib Label )
Eye Disorder (7897970-6)
Adverse event was reported on Oct 27, 2011 by a Male patient taking Pancrelipase (View Usage) (Dosage: Unk) was diagnosed with
- enzyme supplementation
- cystic fibrosis
Patient was taking other medications:
- ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label )
- TOBRAMYCIN (Unk) (View Tobramycin Review and Tobramycin Label )
- AZITHROMYCIN (Unk) (View Azithromycin Review and Azithromycin Label )
- ZOSYN (Unk) (View Zosyn Review and Zosyn Label )
- AUGMENTIN (Unk) (View Augmentin Review and Augmentin Label )
- CIPROFLOXACIN (Unk) (View Ciprofloxacin Review and Ciprofloxacin Label )
- LEXAPRO (Unk) (View Lexapro Review and Lexapro Label )
- CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label )
Eye Disorder (7833242-3)
on Oct 19, 2011 Male patient from UNITED STATES , weighting 136.7 lb, was diagnosed with
- enzyme supplementation
- cystic fibrosis
- depression (depression Questions)
Patient was taking other medications:
- AUGMENTIN (Unk) (View Augmentin Review and Augmentin Label )
- LEXAPRO (Unk) (View Lexapro Review and Lexapro Label )
- AZITHROMYCIN (Unk) (View Azithromycin Review and Azithromycin Label )
- CIPROFLOXACIN (Unk) (View Ciprofloxacin Review and Ciprofloxacin Label )
- ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label )
- TOBRAMYCIN (Unk) (View Tobramycin Review and Tobramycin Label )
- ZOSYN (Unk) (View Zosyn Review and Zosyn Label )
- CLONAZEPAM (Unk) (View Clonazepam Review and Clonazepam Label )
Gastroenteritis, Frequent Bowel Movements (7767629-4)
on Sep 07, 2011 Female patient from UNITED STATES , weighting 13.45 lb, was diagnosed with
- pancreatic insufficiency
Patient was taking other medications:
- AQUADEKS (MULTIVITAMINS) ORAL DROP (View Aquadeks (multivitamins) Oral Drop Review and Aquadeks (multivitamins) Oral Drop Label )
Headache, Dizziness, Dry Mouth, Abnormal Faeces (7647985-8)
Patient was taking Pancrelipase (View Usage). Patient experienced the following unwanted or unexpected effects: headache (headache Questions), dizziness (dizziness Questions), dry mouth, abnormal faeces on Jun 21, 2011 from UNITED STATES Additional patient health information: Male patient , weighting 150.3 lb, was diagnosed with
- pancreatic insufficiency
- prostatomegaly
Patient was taking other medications:
- FINASTERIDE (View Finasteride Review and Finasteride Label )
- PANCREATIN TRIPLE STRENGTH CAP (Daily Dose: 144u, As Used: 48u, Four Creon 12u With Each Meal.) (View Pancreatin Triple Strength Cap Review and Pancreatin Triple Strength Cap Label )
- DOXAZOSIN MESILATE (View Doxazosin Mesilate Review and Doxazosin Mesilate Label )
Scar, Skin Induration, Fibrosis, Dizziness, Nephrogenic Systemic Fibrosis, Mobility Decreased, Arthralgia, Bone Pain, Injury (7599492-9)
Adverse event was reported on Aug 29, 2008 by a Female patient taking Pancrelipase (View Usage) (Dosage: N/A) . Location: UNITED STATES , 43 years of age, weighting 156.0 lb, Patient had the following side effects: scar (scar Questions), skin induration, fibrosis, dizziness (dizziness Questions), nephrogenic systemic fibrosis, mobility decreased, arthralgia, bone pain, injury.
Patient was taking other medications:
- LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label )
- COUMADIN (View Coumadin Review and Coumadin Label )
- OMNISCAN (Unk, Once) (View Omniscan Review and Omniscan Label )
Abdominal Distension, Dyspnoea Exertional, Hypoalbuminaemia, Metastatic Pain, Fatigue, Nausea, Decreased Appetite, Anaemia, Biliary Cancer Metastatic (7548565-5)
on May 31, 2011 Female patient from UNITED STATES , 60 years of age, weighting 121.5 lb, was treated with Pancrelipase (View Usage). After Pancrelipase was administered, patient had the following side effects: abdominal distension, dyspnoea exertional, hypoalbuminaemia, metastatic pain, fatigue, nausea (nausea Questions), decreased appetite, anaemia, biliary cancer metastatic. Pancrelipase dosage: N/A.
Patient was taking other medications:
- HYDROCODONE (View Hydrocodone Review and Hydrocodone Label )
- DRONABINOL (View Dronabinol Review and Dronabinol Label )
- PRALATREXATE (PRALATREXATE) (30 Mg/m2, Iv) (View Pralatrexate (pralatrexate) Review and Pralatrexate (pralatrexate) Label )
- METHOCARBAMOL (View Methocarbamol Review and Methocarbamol Label )
- PROCHLORPERAZINE TAB (View Prochlorperazine Tab Review and Prochlorperazine Tab Label )
- OXYCONTIN (View Oxycontin Review and Oxycontin Label )
Hypoglycaemia, Gait Disturbance, Fracture, Arthralgia, Blood Pressure Increased (7424643-6)
on Apr 18, 2011 Female patient from UNITED STATES , weighting 178.0 lb, was diagnosed with
- pancreatic carcinoma
- hypothyroidism
- pancreatic neuroendocrine tumour
- hyperchlorhydria
- heart rate irregular
- pancreatic operation
Patient was taking other medications:
- LEVOTHYROXINE (112 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label )
- SUTENT (50 Mg, 1x/day) (View Sutent Review and Sutent Label )
- OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label )
- METOPROLOL (25 Mg, 1x/day) (View Metoprolol Review and Metoprolol Label )
- PANTOPRAZOLE (40 Mg, 1x/day) (View Pantoprazole Review and Pantoprazole Label )
Anaemia, Pancreatitis Acute, Pancreatitis Chronic (6058247-7)
Patient was taking Pancrelipase Delayed Release Capsules (View Usage). Patient had the following side effects: anaemia, pancreatitis acute, pancreatitis chronic on Jan 22, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 223.5 lb, was diagnosed with
- pancreatitis chronic
Pancreatitis Acute (5947850-8)
Adverse event was reported on Oct 28, 2008 by a Female patient taking Pancrelipase Delayed Release Capsules (View Usage) (Dosage: Daily Dose: 4 Capsules (one Capsule Per Meal/snack)) was diagnosed with
- pancreatitis chronic
Patient was taking other medications:
- RUN IN PHASE (View Run In Phase Review and Run In Phase Label )
Abdominal Pain, Dehydration, Diarrhoea, Dizziness, Frequent Bowel Movements, Malaise, Nausea, Stomach Discomfort (4806777-5)
on Oct 19, 2005 Male patient from UNITED STATES , 52 years of age, weighting 243.0 lb, was diagnosed with
- lipase increased
- pancreatitis
Share Your Experience, Discuss with Others
Pancrelipase InformationAlternative PANCRELIPASE Names:PANCRELIP Substance:PANCRELIP Side Effects reported to FDA: 16. View FDA Adverse Reports Pancrelipase safety alerts: No Reported deaths: 1 Reported hospitalizations: 3
| ||||